Summary of Hallmarks enriched in MaPR172H/- mammary tumors compared to MaP/- mammary tumors.
No takes yet. Share an insight, caveat, or question.
McDaniel et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: